A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
Clinical trial NCT02633657 · WITHDRAWN
Trial details
- NCT number
- NCT02633657
- Sponsor
- XenoPort, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2017-07-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.